Biogen reported $966.2M in Pre-Tax Profit for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Acorda Therapeutics ACOR:US $ -28.7M 9.15M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Bayer BAYN:GR € 1537M 1825M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Sanofi SAN:FP € 2180M 376M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Teva Pharmaceutical TEVA:IT 794M 650M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
United Therapeutics UTHR:US $ 216.5M 184M
YTE INCY:US $ 199.6M 31.06M